Skip to main content

Advertisement

SpringerLink
Log in

Early diagnosis of early-onset sarcoidosis: a case report with functional analysis and review of the literature

  • Case Based Review
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

This study examined the pathogenesis of early-onset sarcoidosis (EOS) in a patient with a rare NOD2 mutation and surveyed the literature to identify the hallmark features for early diagnosis. An infant girl suffering from prolonged fever and skin rash of multiple pinkish papules and subsequent erythema nodosum was referred to our institution. Skin biopsy and DNA sequencing were performed along with cytokine profiling of the patient’s serum and stimulated mononuclear cells. NF-κB activation was analyzed using transfected cells. Multiple non-caseating granuloma inclusions were recognized in biopsy specimens obtained from the patient’s rash. DNA sequencing revealed a very rare heterozygous Met513Thr (M513T) mutation in NOD2. Mononuclear cells produced a low amount of IL-1β upon stimulation as compared with normal control cells. Mutated NOD2 transfection enhanced NF-κB activation. We suspected that the M513T mutation in NOD2 decreased IL-1β production and enhanced NF-κB activation, which was likely responsible for the patient’s granuloma involvement. A comprehensive review of the literature on 30 cases of sporadic type of EOS revealed that all patients had cutaneous manifestations, with all but one displaying granulation. A majority of EOS patients have R334W/Q. But about half of sporadic EOS had NOD2 mutations other than R334W/Q, as in the present case. Accordingly, skin rash with granuloma formation and specific NOD2 mutations may represent early diagnostic hallmarks of EOS in infants with persistent inflammation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Blau EB (1985) Familial granulomatous arthritis, iritis, and rash. J Pediatr 107:689–693

    Article  CAS  PubMed  Google Scholar 

  2. Rose CD, Doyle TM, McIlvain-Simpson G, Coffman JE, Rosenbaum JT, Davey MP et al (2005) Blau syndrome mutation of CARD15/NOD2 in sporadic early onset granulomatous arthritis. J Rheumatol 32:373–375

    CAS  PubMed  Google Scholar 

  3. Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, Hafner R et al (2001) CARD15 mutations in Blau syndrome. Nat Genet 29:19–20

    Article  CAS  PubMed  Google Scholar 

  4. Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J et al (2003) Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease J Biol Chem 278:5509–5512

    CAS  PubMed  Google Scholar 

  5. Hasegawa M, Fujimoto Y, Lucas PC, Nakano H, Fukase K, Nunez G et al (2008) A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation. EMBO J 27:373–383

    Article  CAS  PubMed  Google Scholar 

  6. Shigemura T, Kaneko N, Kobayashi N, Kobayashi K, Takeuchi Y, Nakano N et al (2016) Novel heterozygous C243Y A20/TNFAIP3 gene mutation is responsible for chronic inflammation in autosomal-dominant Behcet’s disease. RMD open 2:e000223

    Article  PubMed  PubMed Central  Google Scholar 

  7. Chamaillard M, Philpott D, Girardin SE, Zouali H, Lesage S, Chareyre F et al (2003) Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc Natl Acad Sci U S A 100:3455–3460

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Kanazawa N, Okafuji I, Kambe N, Nishikomori R, Nakata-Hizume M, Nagai S et al (2005) Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood 105:1195–1197

    Article  CAS  PubMed  Google Scholar 

  9. Martin TM, Zhang Z, Kurz P, Rose CD, Chen H, Lu H et al (2009) The NOD2 defect in Blau syndrome does not result in excess interleukin-1 activity. Arthritis Rheum 60:611–618

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Masumoto J, Yamazaki T, Ohta K, Nakayama J, Agematsu K (2009) Interleukin-1beta suppression in Blau syndrome: comment on the article by Martin et al. Arthritis Rheum 60:2544–2545

    Article  PubMed  Google Scholar 

  11. Jabs DA, Houk JL, Bias WB, Arnett FC (1985) Familial granulomatous synovitis, uveitis, and cranial neuropathies. Am J Med 78:801–804

    Article  CAS  PubMed  Google Scholar 

  12. Okafuji I, Nishikomori R, Kanazawa N, Kambe N, Fujisawa A, Yamazaki S et al (2009) Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis. Arthritis Rheum 60:242–250

    Article  CAS  PubMed  Google Scholar 

  13. Kanazawa N, Matsushima S, Kambe N, Tachibana T, Nagai S, Miyachi Y (2004) Presence of a sporadic case of systemic granulomatosis syndrome with a CARD15 mutation. J Invest Dermatol 122:851–852

    Article  CAS  PubMed  Google Scholar 

  14. La Torre F, Lapadula G, Cantarini L, Lucherini OM, Iannone F (2015) Early-onset sarcoidosis caused by a rare CARD15/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literature. Clin Rheumatol 34:391–395

    Article  PubMed  Google Scholar 

  15. Caso F, Costa L, Rigante D, Vitale A, Cimaz R, Lucherini OM et al (2014) Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis. Autoimmun Rev 13:1220–1229

    Article  PubMed  Google Scholar 

  16. Arostegui JI, Arnal C, Merino R, Modesto C, Antonia Carballo M, Moreno P et al (2007) NOD2 gene-associated pediatric granulomatous arthritis: clinical diversity, novel and recurrent mutations, and evidence of clinical improvement with interleukin-1 blockade in a Spanish cohort. Arthritis Rheum 56:3805–3813

    Article  CAS  PubMed  Google Scholar 

  17. Sugiyama R, Agematsu K, Migita K, Nakayama J, Mokuda S, Ogura F et al (2014) Defect of suppression of inflammasome-independent interleukin-8 secretion from SW982 synovial sarcoma cells by familial Mediterranean fever-derived pyrin mutations. Mol Biol Rep 41:545–553

    Article  CAS  PubMed  Google Scholar 

  18. Caso F, Galozzi P, Costa L, Sfriso P, Cantarini L, Punzi L (2015) Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn’s disease. RMD open 1:e000097

    Article  PubMed  PubMed Central  Google Scholar 

  19. Janssen CE, Rose CD, De Hertogh G, Martin TM, Bader Meunier B, Cimaz R et al (2012) Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2-related disorders Blau syndrome and Crohn disease. J Allergy Clin Immunol 129:1076–1084

    Article  CAS  PubMed  Google Scholar 

  20. Auphan N, DiDonato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286–290

    Article  CAS  PubMed  Google Scholar 

  21. Milman N, Andersen CB, Hansen A, van Overeem HT, Nielsen FC, Fledelius H et al (2006) Favourable effect of TNF-alpha inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation. APMIS 114:912–919

    Article  PubMed  Google Scholar 

  22. Sakurai Y, Nakajima M, Kamisue S, Nishimura Y, Ueda T, Miyagawa S et al (1997) Preschool sarcoidosis mimicking juvenile rheumatoid arthritis: the significance of gallium scintigraphy and skin biopsy in the differential diagnosis. Acta Paediatr Jpn 39:74–78

    Article  CAS  PubMed  Google Scholar 

  23. Yasui K, Yashiro M, Tsuge M, Manki A, Takemoto K, Yamamoto M et al (2010) Thalidomide dramatically improves the symptoms of early-onset sarcoidosis/Blau syndrome: its possible action and mechanism. Arthritis Rheum 62:250–257

    Article  CAS  PubMed  Google Scholar 

  24. Ukae S, Tsutsumi H, Adachi N, Takahashi H, Kato F, Chiba S (1994) Preschool sarcoidosis manifesting as juvenile rheumatoid arthritis: a case report and a review of the literature of Japanese cases. Acta Paediatr Jpn 36:515–518

    Article  CAS  PubMed  Google Scholar 

  25. Borzutzky A, Fried A, Chou J, Bonilla FA, Kim S, Dedeoglu F (2010) NOD2-associated diseases: bridging innate immunity and autoinflammation. Clin Immunol 134:251–261

    Article  CAS  PubMed  Google Scholar 

  26. Ikeda K, Kambe N, Takei S, Nakano T, Inoue Y, Tomiita M et al (2014) Ultrasonographic assessment reveals detailed distribution of synovial inflammation in Blau syndrome. Arthritis Res Ther 16:R89

    Article  PubMed  PubMed Central  Google Scholar 

  27. Yotsumoto S, Takahashi Y, Takei S, Shimada S, Miyata K, Kanzaki T (2000) Early onset sarcoidosis masquerading as juvenile rheumatoid arthritis. J Am Acad Dermatol 43:969–971

    Article  CAS  PubMed  Google Scholar 

  28. Jain L, Gupta N, Reddy MM, Mittal R, Barik MR, Panigrahi B et al. (2016) A novel mutation in helical domain 2 of NOD2 in sporadic Blau syndrome. Ocul Immunol Inflamm :1–3.

  29. Meiorin SM, Espada G, Costa CE, Tartara A, De Matteo E, Wouters C et al (2007) Granulomatous nephritis associated with R334Q mutation in NOD2. J Rheumatol 34:1945–1947

    PubMed  Google Scholar 

  30. Priori R, Bombardieri M, Spinelli FR, Merlin F, Miceli-Richard C, La Cava M et al (2004) Sporadic Blau syndrome with a double CARD15 mutation. Report of a case with lifelong follow-up. Sarcoidosis Vasc Diffuse Lung Dis 21:228–231

    PubMed  Google Scholar 

  31. Okada S, Konishi N, Tsumura M, Shirao K, Yasunaga S, Sakai H et al (2009) Cardiac infiltration in early-onset sarcoidosis associated with a novel heterozygous mutation, G481D, in CARD15. Rheumatology (Oxford) 48:706–707

    Article  CAS  Google Scholar 

  32. Sakai H, Ito S, Nishikomori R, Takaoka Y, Kawai T, Saito M et al (2010) A case of early-onset sarcoidosis with a six-base deletion in the NOD2 gene. Rheumatology (Oxford) 49:194–196

    Article  CAS  Google Scholar 

  33. Stoevesandt J, Morbach H, Martin TM, Zierhut M, Girschick H, Hamm H (2010) Sporadic Blau syndrome with onset of widespread granulomatous dermatitis in the newborn period. Pediatr Dermatol 27:69–73

    Article  PubMed  Google Scholar 

  34. Martin J, Kodjikian L, Duquesne A, Le Scanff J, Seve P (2011) Blau syndrome. QJM 104:997–998

    Article  CAS  PubMed  Google Scholar 

  35. Raiji VR, Miller MM, Jung LK (2011) Uveitis in Blau syndrome from a de novo mutation of the NOD2/CARD15 gene. J AAPOS 15:205–207

    Article  PubMed  Google Scholar 

  36. Jimenez-Martinez MC, Cruz F, Groman-Lupa S, Zenteno JC (2011) Immunophenotyping in peripheral blood mononuclear cells, aqueous humour and vitreous in a Blau syndrome patient caused by a novel NOD2 mutation. Int J Immunogenet 38:233–242

    Article  CAS  PubMed  Google Scholar 

  37. Sharma SM, Martin TM, Rose CD, Dick AD, Ramanan AV (2011) Distinguishing between the innate immune response due to ocular inflammation and infection in a child with juvenile systemic granulomatous disease treated with anti-TNFalpha monoclonal antibodies. Rheumatology (Oxford) 50:990–992

    Article  Google Scholar 

  38. Inoue Y, Kawaguchi Y, Shimojo N, Yamaguchi K, Morita Y, Nakano T et al (2013) A case of infantile Takayasu arteritis with a p.D382E NOD2 mutation: an unusual phenotype of Blau syndrome/early-onset sarcoidosis? Mod Rheumatol 23:837–839

    Article  PubMed  Google Scholar 

  39. Simonini G, Xu Z, Caputo R, De Libero C, Pagnini I, Pascual V et al (2013) Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis. Arthritis Rheum 65:513–518

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Chauhan K, Michet C (2014) A case of blau syndrome. Case Rep Rheumatol 2014:216056

    PubMed  PubMed Central  Google Scholar 

  41. Arvesen KB, Herlin T, Larsen DA, Koppelhus U, Ramsing M, Skytte AB et al. (2016) Diagnosis and treatment of Blau syndrome/early-onset sarcoidosis, an autoinflammatory granulomatous disease, in an infant. Acta Derm Venereol.

  42. Zeybek C, Basbozkurt G, Gul D, Demirkaya E, Gok F (2015) A new mutation in blau syndrome. Case Rep Rheumatol 2015:463959

    PubMed  PubMed Central  Google Scholar 

  43. Paparizos SC, Goldstein DA, Bouhenni RA, Steiner S, Dunmire JJ, Edward DP (2012) Immunohistochemical evidence of specific iris involvement in Blau syndrome. Ocul Immunol Inflamm 20:471–474

    Article  CAS  PubMed  Google Scholar 

  44. Coto-Segura P, Mallo-Garcia S, Costa-Romero M, Arostegui JI, Yague J, Ramos-Polo E et al (2007) A sporadic case of early-onset sarcoidosis resembling Blau syndrome due to the recurrent R334W missense mutation on the NOD2 gene. Br J Dermatol 157:1257–1259

    Article  CAS  PubMed  Google Scholar 

  45. Ohga S, Ichino K, Urabe K, Ishimura M, Takada H, Nishikomori R et al (2008) Early-onset sarcoidosis mimicking refractory cutaneous histiocytosis. Pediatr Blood Cancer 50:723–726

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We express our sincere appreciation to the doctors in the Department of Dermatology at Shinshu University Hospital for skin biopsy procedures and Dr. S. Ohara for performing DNA sequencing.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Shinshu University School of Medicine, Asahi 3-1-1, Matsumoto, 390-8621, Japan

    Yusuke Takeuchi, Tomonari Shigemura & Norimoto Kobayashi

  2. Department of Pathology, Ehime University Proteo-Science Center and Graduate School of Medicine, Ehime, Japan

    Naoe Kaneko, Tomoyuki Iwasaki & Junya Masumoto

  3. Nagano Children’s Hospital, Azumino, Japan

    Kisei Minami

  4. Department of Infection and Host Defense, Graduate School of Medicine, Shinshu University, Matsumoto, Japan

    Keiko Kobayashi & Kazunaga Agematsu

Authors
  1. Yusuke Takeuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tomonari Shigemura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Norimoto Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Naoe Kaneko
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tomoyuki Iwasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kisei Minami
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Keiko Kobayashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Junya Masumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kazunaga Agematsu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yusuke Takeuchi.

Ethics declarations

This genetic analysis was approved by the institutional review board of Shinshu University and performed in accordance with the ethical tenets set forth in the 1964 Declaration of Helsinki and its later amendments. Written informed consent was obtained from the patient’s parents for publication of this case report and its accompanying images.

Disclosures

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Takeuchi, Y., Shigemura, T., Kobayashi, N. et al. Early diagnosis of early-onset sarcoidosis: a case report with functional analysis and review of the literature. Clin Rheumatol 36, 1189–1196 (2017). https://doi.org/10.1007/s10067-017-3544-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-017-3544-6

Keyword

Search

Navigation